Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
NKTR
Nektar Therapeutics
Last Price:
$0.74
Seasonality Move:
-0.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and NKTR is experiencing slight selling pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.7 | Buy |
| 20-day SMA: | 0.63 | Buy |
| 50-day SMA: | 0.77 | Sell |
| 200-day SMA: | 1.06 | Sell |
| 8-day EMA: | 0.71 | Buy |
| 20-day EMA: | 0.69 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 0.96 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 55.6 | Buy |
| Chaikin Money Flow: | -67822 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.75) | Buy |
| Bollinger Bands (100): | (0.69 - 1.01) | Sell |
Nektar Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.74 while NKTR 8-day simple moving average is 0.70, which is a Buy signal.
-
The stock price of NKTR is 0.74 while Nektar Therapeutics 20-day SMA is 0.63, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 0.77 while NKTR share price is 0.74, making it a Sell technically.
-
NKTR stock price is 0.74 and Nektar Therapeutics 200-day simple moving average is 1.06, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $0.74. The Score for NKTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
137.8M
Price in USD:
0.74
Share Volume:
951.2K
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.43
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.74 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.74 while NKTR 8-day exponential moving average is 0.71, which is a Buy signal.
-
The stock price of NKTR is 0.74 while Nektar Therapeutics 20-day EMA is 0.69, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 0.74 while NKTR share price is 0.74, making it a Sell technically.
-
NKTR stock price is 0.74 and Nektar Therapeutics 200-day simple moving average is 0.96, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 55.6, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.55 - 0.75), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.69 - 1.01), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.